SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA accelerated approval of Inovios competing RRP treatment has raised concerns about competition for Precigens PAPZIMEOS and prompted debate over potential sales impact. Traders disagree on whether Inovios treatment could challenge Precigens position or whether PAPZIMEOSs established commercial lead and full approval offer an advantage over the rivals accelerated approval and commercialization hurdles.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons better-than-expected third-quarter results, supported by strong refining performance, are driving attention. Traders are reacting positively to the earnings beat and heavy call activity, while some question whether unusually strong refining margins can last.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotifys Q3 results and stronger-than-expected Q4 profit outlook are driving attention, with traders emphasizing subscriber growth, improving margins, and better ad trends despite revenue and EPS misses. The sharp rise has surprised skeptics, while bulls argue the forward guidance matters more than the quarters headline results.

JasmyCoin (JASMY) is a cryptocurrency launched in 2016and operates on the Ethereum platform. JasmyCoin has a current supply of 50,000,000,000 with 49,444,999,677.16957912 in circulation. The last known price of JasmyCoin is 0.00385003 USD and is up 3.25 over the last 24 hours. It is currently trading on 374 active market(s) with $20,884,591.23 traded over the last 24 hours. More information can be found at https://www.jasmy.co.jp/en_company.html.

JasmyCoin

Jasmys announced AppBank collaboration and planned Money Twin personal-AI service are drawing attention alongside a burst of trading activity. Bulls see the partnership and JasmyChain as steps toward real utility, while skeptics argue that adoption and resulting demand for JASMY remain unproven; discussion also centers on volatile price moves and dip buying.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys quarterly results beat expectations, with strong theme-park performance and improving streaming profitability driving a broadly constructive reaction and renewed analyst optimism. Some traders remain skeptical, pointing to the stocks long-running sluggishness and questioning whether the results can support a sustained re-rating.

Chainlink (LINK) is a cryptocurrency launched in 2017and operates on the Ethereum platform. Chainlink has a current supply of 1,000,000,000 with 748,099,970.42488396 in circulation. The last known price of Chainlink is 11.42916419 USD and is up 8.20 over the last 24 hours. It is currently trading on 2313 active market(s) with $611,471,639.23 traded over the last 24 hours. More information can be found at https://chain.link/.

ChainLink

LINKs sharp rebound and breakout attempt have sparked bullish momentum and heavy volume, with traders pointing to renewed crypto risk appetite and Chainlinks institutional and tokenization integrations as supportive context. Others warn the move may fade, citing resistance, volatile pullbacks, and doubts that network adoption will translate into lasting value for the LINK token.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,174,495.43496562. The last known price of Ethereum is 2,241.26797415 USD and is down -0.51 over the last 24 hours. It is currently trading on 14214 active market(s) with $20,040,937,711.35 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

The reported record Binance hack is driving concern about crypto exchange security and possible selling pressure across the market, including Ethereum. Traders are split between expecting further downside as confidence and risk appetite weaken and viewing ETHs relative resilience and dip buying as signs the shock may be contained.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

EWY is drawing attention as South Korean equities sell off amid an unwind in crowded AI and memory-chip trades, with Samsung and SK Hynix weakness and leveraged positions amplifying volatility. Traders are split between expecting further forced selling and viewing the pullback as a potential buying opportunity.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios Q3 results beat expectations and full-year guidance rose, but shares sold off sharply after its Q4 outlook signaled slower organic growth and messaging deceleration. Traders are debating whether the strong results and potential AI-related demand offset the weaker near-term outlook; many view guidance as the main driver of the drop.

Amp (AMP) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Amp has a current supply of 99,720,267,351.28921674 with 89,781,193,103.18022 in circulation. The last known price of Amp is 0.0006528 USD and is up 0.85 over the last 24 hours. It is currently trading on 193 active market(s) with $5,174,420.89 traded over the last 24 hours. More information can be found at https://amp.xyz.

AMP Token

A sharp, high-volume rally has put AMP in focus, though traders point to no confirmed new catalyst. Bulls see a breakout and connect the move to AMPs Flexa collateral role and Anvil developments, while skeptics call it another speculative pump and question whether adoption will translate into meaningful use.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Cannabis Stocks To Watch Today - January 1st

Tilray Brands, Canopy Growth, Aurora Cannabis, SNDL, Cronos Group, WM Technology, and InterCure are the seven Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis...

InterCure To Buy ISHI In All-Stock Transaction – Find Out More

Equity

The company said that it would acquire ISHI in two phases for a total consideration of 4.92 million shares. 

InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies in the Biomed Sector and Investments in the Medical Cannabis Sector segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.

Intercure Ltd

Bullish Sentiment

InterCure (INCR) on Friday announced that it will acquire premium medical cannabis technology and brand company Botanico, also known as ISHI. &nbsp;The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/09/19/3153163/0/en/InterCure-Announces-Strategic-Acquisition-of-ISHI-Unlocking-Access-to-Premium-U-S-Cannabis-Technology-and-Brands.html">said</a> that it would acquire ISHI in two phases. The company would initially acquire 50% of equity for about 2.47 million InterCure ordinary shares. The remaining 50% will be acquired either 24 months from the initial closing, in consideration for an additional 2.46 million InterCure ordinary shares, or upon ISHI achieving positive operating profitability for at least three consecutive months, InterCure said.<a href="https://stocktwits.com/symbol/INCR">INCR stock</a> traded 2% higher at the time of writing. On Stocktwits, retail sentiment around INCR stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels.InterCure said that the acquisition comes as the Trump administration reportedly explores the rescheduling of cannabis from Schedule I to Schedule III. This regulatory shift could unlock unprecedented opportunities for international cannabis companies such as InterCure, it added.InterCure stated that the acquisition would provide access to ISHI's premium indoor product supply, brand portfolio, technology, and operational systems, which will enhance the former’s supply chain and distribution operations while supporting expansion into international markets. The company will also gain access to exclusive partnerships with premium U.S. brands, such as medical cannabis company The Flowery.Following the acquisition, ISHI founders Omer Layani and Dor Hershkovitz will join the InterCure leadership team, and all existing ISHI stock options will be converted to InterCure options, maintaining the original vesting schedules."By acquiring ISHI, we gain immediate access to some of America's most sought-after cannabis genetics and proven operational technologies at exactly the moment when we are encouraged by the reported recent momentum in the U.S. around potential cannabis rescheduling,” said CEO Alexander Rabinovich, while adding that the company expects it to become accretive to its business model within the first year.The transaction is expected to close in the first quarter of 2026, subject to regulatory approvals.INCR stock has fallen 4% this year and by approximately 18% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/intellia-therapeutics-stock-gets-price-target-hike-from-hc-wainwright/chD3TDgR3Rw">Intellia Therapeutics Stock Gets A Price Target Hike From HC Wainwright – Check Out The Details</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.97
Prev Close	$4.12
Open	$4.17
Dividend Yield	0.00%
50-Day Moving Average	$5.09
Beta	0.70
Avg. Volume	7,059.42
PE Ratio	-3.97

52-Week High	$7.55
52-Week Low	$3.40
Market Capitalization	$47.03M
EPS (Annual)	-$0.9632
Price to Book	0.35
Revenue Per Employee	$274,864.57

Feed

News

Sentiment

Earnings

Fundamentals

Info

INCR Fundamentals